NCT06301880View on ClinicalTrials.gov

Effect of Topically-applied Milrinone or Nitroglycerin on Internal Mammary Artery Free Flow

PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Internal Mammary Artery SyndromeVasodilation
Interventions
DRUG

The topical application of a vasodilator on the LIMA graft

Patients were randomly assigned to receive the topical application of one of three agents: milrinone (Baxter Pharmaceuticals, Ahmedabad, India) 10 mg in 20 ml of dextrose 5%, nitroglycerin (Caspian Tamin Pharmaceutical, Guilan, Iran) 10 mg in 20 ml of normal saline, or normal saline (0.9% sodium chloride solution) as control.

Trial Locations (1)

Unknown

Damascus University Cardiac Surgery Hospital, Damascus

All Listed Sponsors
lead

Damascus University

OTHER

NCT06301880 - Effect of Topically-applied Milrinone or Nitroglycerin on Internal Mammary Artery Free Flow | Biotech Hunter | Biotech Hunter